mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.004 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
0.004 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.005 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.006 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.009 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.009 |